Average Co-Inventor Count = 2.18
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aegis Therapeutics, LLC (6 from 35 patents)
2. Teva Women's Health, Inc. (4 from 20 patents)
3. Barr Laboratories, Inc. (3 from 16 patents)
4. Duramed Pharmaceuticals, Inc. (2 from 14 patents)
5. Other (1 from 832,891 patents)
6. Ars Pharmaceuticals Inc. (0 patent)
16 patents:
1. 12324838 - Intranasal epinephrine formulations and methods for the treatment of disease
2. 11918655 - Intranasal epinephrine formulations and methods for the treatment of disease
3. 11744895 - Intranasal epinephrine formulations and methods for the treatment of disease
4. 11717571 - Intranasal epinephrine formulations and methods for the treatment of disease
5. 11191838 - Intranasal epinephrine formulations and methods for the treatment of disease
6. 10682414 - Intranasal epinephrine formulations and methods for the treatment of disease
7. 8680084 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
8. 8338396 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
9. 7858605 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
10. 7855190 - Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
11. 7615545 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
12. 7320969 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
13. 6613758 - Method for treating osteoporosis in castrated prostatic cancer patients
14. 616550 - Methods for treating hot flashes and improving the quality of life of
15. 6165504 - Methods for treating hot flashes and improving the quality of life of